Navigation Links
Pharmacopeia to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Date:10/22/2007

copeia's expectations concerning the development priorities of its collaborators, their ability to successfully develop compounds and its receipt of milestones and royalties from the collaborations, Pharmacopeia's anticipated operating results, financial condition, liquidity and capital resources, Pharmacopeia's expectations concerning the legal protections afforded by U.S. and international patent law, Pharmacopeia's ability to pursue the development of new compounds and other business matters without infringing the patent rights of others, additional competition, and changes in economic conditions.

Further information about these and other relevant risks and uncertainties may be found in Pharmacopeia's Reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Pharmacopeia urges you to carefully review and consider the disclosures found in its filings which are available in the SEC EDGAR database at http://www.sec.gov and from Pharmacopeia at http://www.pharmacopeia.com. All forward-looking statements in this press release and oral statements made with respect to information contained in this press release are qualified entirely by the cautionary statements included in this press release and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by such forward-looking statements. These forward-looking statements speak only as of the date of this press release. Pharmacopeia undertakes no obligation to (and expressly disclaims any such obligation to) publicly update or revise the statements made herein or the risk factors that may relate thereto whether as a result of new information, future events, or otherwise.

Contact:

Amy P. Sharpless

Corporate Communications

(609) 452-3643

ir_pr@pcop.com
'/>"/>

SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... (PRWEB) June 19, 2013 An article posted ... on the increasing number of uses for probiotics. The article ... qualities, and the associate benefits may beeb listed, the ... inflammation, and helping clear skin conditions. While the total uses ... light on the the uses of these “miracle” bacterium, and ...
(Date:6/19/2013)... June 19, 2013 Synthetic Biologics, Inc. (NYSE MKT: ... treatment of serious infectious diseases, announced today that Jeffrey ... Annual OneMedForum New York Conference on Thursday, June 27, 2013 ... . Mr. Riley is scheduled to present at 8:40 ... Biologics, presentation can be accessed by logging onto the web ...
(Date:6/19/2013)... 2013 Bayer CropScience will honor Illinois ... Care Community Leadership Award. The award will be announced ... in Washington, D.C., an event where supporters of pollinator ... food supply. , The Bayer Bee Care Community ... of the honey bee colony to benefit their community. ...
(Date:6/19/2013)... BioConvergence team members Curtis Strother ... 2013’s BioLogistics Summit in San Francisco earlier this ... Chain IQ and IQPC, addressed the increasingly complex ... part, attributed to current trends of globalization, outsourcing, ... trends is an increase in movement, which is ...
Breaking Biology Technology:Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2Synthetic Biologics to Present at OneMedForum New York 2013 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2
... ValGenesis, Inc., a world-class provider of Validation Lifecycle ... ValGenesis Suite 2.5 has achieved SAP certification as ... this certified integration status deepens ValGenesis, active and ... SAP Integration and Certification Center (SAP ICC) has ...
... BioLife Solutions , Inc. (OTCBB: BLFS), a leading ... hypothermic storage and cryopreservation freeze ... that TRANSFUSION , the foremost publication in ... has published a peer-reviewed journal article reporting positive ...
... Inspired Engineering at Harvard University have developed a robotic ... specific cell targets within a complex mixture of cell ... cancer cells to self-destruct. Inspired by the mechanics of ... day be used to program immune responses to treat ...
Cached Biology Technology:ValGenesis Suite 2.5 Certified by SAP as Powered by SAP NetWeaver® 2ValGenesis Suite 2.5 Certified by SAP as Powered by SAP NetWeaver® 3Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION 2Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION 3Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION 4Harvard's Wyss Institute develops DNA nanorobot to trigger targeted therapeutic responses 2Harvard's Wyss Institute develops DNA nanorobot to trigger targeted therapeutic responses 3
(Date:6/18/2013)... Obar, Ph.D., Department of Immunology and Infectious Diseases, Montana ... Young Investigator Award for his research on factors affecting ... , Obar earned his B.A. in Microbiology from ... complete his Ph.D. in Microbiology and Immunology from Dartmouth ... research in Edward Usherwood,s laboratory at the Geisel School ...
(Date:6/18/2013)... is estimated that between 5% and 10% of breast ... to say that these tumours are attributable to inherited ... or BRCA2. In patients with these mutations, PARP inhibitors, ... results that make them a new option for personalised ... latest studies indicate that a fraction of these patients ...
(Date:6/18/2013)... that weight gain and increased head size in the first month ... early school age. , The study was led by University of ... children who were born full-term. , The results, published in the ... on 40% of their birthweight in the first four weeks had ... years of age, compared with babies who only put on 15% ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Joshua Obar 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2IQ link to baby's weight gain in first month 2
... known that excessive text messaging can result in sore thumbs, ... arms and hands. Young adults with symptoms in these parts ... to a study at the Sahlgrenska Academy, University of Gothenburg, ... 56 young adults who text message on a daily basis. ...
... warming whips up more powerful and frequent hurricanes and storms, ... to breed and recover from damage. That,s one of ... of corals in the wake of large climate-driven bleaching and ... recruitment the regrowth of young corals drops sharply ...
... San Jose, California, June 23, 2009 Chronix ... peer-reviewed journal further confirms the potential diagnostic and prognostic ... early stage disease. These DNA fragments, referred to ... in trace amounts during the disease process. Chronix Biomedical ...
Cached Biology News:How to text message and avoid pain 2Coral face 'a stormy future' 2Study shows Chronix technology using serum DNA can identify early presence of disease 2
Request Info...
Polyclonal Antibody to CLAN...
Goat polyclonal to MLH3 ( Abpromise for all tested applications). entrezGeneID: 27030 SwissProtID: Q9UHC1...
Rabbit polyclonal to NMDAR1 e/f/g/h ( Abpromise for all tested applications)....
Biology Products: